BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar P, Sharma M, Kulkarni A, Rao PN. Pathogenesis of Liver Injury in Coronavirus Disease 2019. J Clin Exp Hepatol. 2020;10:641-642. [PMID: 32837092 DOI: 10.1016/j.jceh.2020.05.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ng A. Prognostic value of bilirubin and drug interactions. BMJ Open Gastroenterol 2021;8:e000625. [PMID: 34006605 DOI: 10.1136/bmjgast-2021-000625] [Reference Citation Analysis]
2 Premkumar M, Kedarisetty CK. Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease. J Clin Transl Hepatol 2021;9:256-64. [PMID: 34007808 DOI: 10.14218/JCTH.2021.00055] [Reference Citation Analysis]
3 Kulkarni AV, Parthasarathy K, Kumar P, Sharma M, Reddy R, Chaitanya Akkaraju Venkata K, Gupta R, Gupta A, Swaroop S, Giri Vishwanathan P, Senapathy G, Menon PB, Reddy ND, Padaki NR. Early liver transplantation after COVID-19 infection: The first report. Am J Transplant 2021;21:2279-84. [PMID: 33508881 DOI: 10.1111/ajt.16509] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
4 Kulkarni AV, Vasireddy S, Sharma M, Reddy ND, Padaki NR. COVID-19 Masquerading as Autoimmune Hepatitis (AIH) Flare- The First Report. J Clin Exp Hepatol 2021. [PMID: 34539127 DOI: 10.1016/j.jceh.2021.09.007] [Reference Citation Analysis]
5 Ali FEM, Mohammedsaleh ZM, Ali MM, Ghogar OM. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. World J Gastroenterol 2021; 27(15): 1531-1552 [PMID: 33958841 DOI: 10.3748/wjg.v27.i15.1531] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Alotaibi F. Current strategies in diagnostics and therapeutics against novel coronavirus disease (COVID-19). Acta Pharmaceutica 2022;72:171-97. [DOI: 10.2478/acph-2022-0014] [Reference Citation Analysis]
7 Chan C, Foster ST, Chan KG, Cacace MJ, Ladd SL, Sandum CT, Wright PT, Volmert B, Yang W, Aguirre A, Li W, Wright NT. Repositioned Drugs for COVID-19-the Impact on Multiple Organs. SN Compr Clin Med 2021;:1-18. [PMID: 33898925 DOI: 10.1007/s42399-021-00874-8] [Reference Citation Analysis]
8 Choudhary NS, Dhampalwar S, Saraf N, Soin AS. Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation. J Clin Exp Hepatol 2021. [PMID: 33994708 DOI: 10.1016/j.jceh.2021.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Dawood RM, Salum GM, El-Meguid MA. The Impact of COVID-19 on Liver Injury: COVID-19 and Liver Injury. Am J Med Sci 2021:S0002-9629(21)00400-6. [PMID: 34752738 DOI: 10.1016/j.amjms.2021.11.001] [Reference Citation Analysis]
10 Jothimani D, Vij M, Sanglodkar U, Patil V, Sachan D, Narasimhan G, Kaliamoorthy I, Rela M. Severe Jaundice in a COVID-19 Patient-Virus or Drug? J Clin Exp Hepatol 2021;11:407-8. [PMID: 33654344 DOI: 10.1016/j.jceh.2021.02.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Afify S, Eysa B, Hamid FA, Abo-Elazm OM, Edris MA, Maher R, Abdelhalim A, Abdel Ghaffar MM, Omran DA, Shousha HI. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study. World J Gastroenterol 2021; 27(42): 7362-7375 [PMID: 34876795 DOI: 10.3748/wjg.v27.i42.7362] [Reference Citation Analysis]